NS Pharma, Inc. has recently released data indicating that there may be good long-term safety and clinical benefits for boys with Duchenne muscular dystrophy, who had been treated with vitolarsen for up to 109 weeks.
Our MDUK Muscles Matter 2021 online seminar series continued on Tuesday 13 July with a seminar on cardiac management.
Ways you can get involved
For over 50 years, we've been here for people living with muscle-wasting conditions. We couldn't do this without your help. Thank you.
Support for our work is more crucial than ever, so we've got lots of ideas about how you can help us fundraise.
Our brilliant volunteers help us deliver services, fundraise and raise awareness about muscle-wasting conditions.